← Open Payments lookup

LYNNE PAPPAS: Open Payments

NPI 1427069194 · PARADISE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$570 in 37 payments from 7 companies in 2025. Trend: 2023 $584 · 2024 $285 · 2025 $570

Food & beverage: $470Education: $100
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.25$180
Neurocrine BioSciences, Inc.2$146
Teva Pharmaceuticals USA, Inc.6$138
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$44
Janssen Pharmaceuticals, Inc1$21
E.R. Squibb & Sons, L.L.C.1$21
ABBVIE INC.1$21

Products named: INGREZZA, ABILIFY MAINTENA, ABILIFY ASIMTUFII, CAPLYTA, AUSTEDO XR, REXULTI, INVEGA SUSTENNA, COBENFY.

Industry payments across CA — which companies pay providers there.